UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Multiple pathologies are common and related to dementia in the oldest-old: The 90+ Study

Neurology, 2015-08, Vol.85 (6), p.535-542

2015

Volltextzugriff (PDF)

Age of onset of hypertension and risk of dementia in the oldest-old: The 90+ Study

Alzheimer's & dementia, 2017-02, Vol.13 (2), p.103-110

2017

Volltextzugriff (PDF)

Late-Onset Alzheimer Disease

Neurologic clinics, 2017-05, Vol.35 (2), p.283-293

2017

Volltextzugriff (PDF)

Sound Body Sound Mind? Physical Performance and the Risk of Dementia in the Oldest-Old: The 90+ Study

Journal of the American Geriatrics Society (JAGS), 2016-07, Vol.64 (7), p.1408-1415

2016

Volltextzugriff (PDF)

Development of third generation anti-EGFRvIII chimeric T cells and EGFRvIII-expressing artificial antigen presenting cells for adoptive cell therapy for glioma

PloS one, 2018-07, Vol.13 (7), p.e0199414-e0199414

2018

Volltextzugriff (PDF)

What works and what does not work in Alzheimer’s disease? From interventions on risk factors to anti‐amyloid trials

Journal of neurochemistry, 2020-09, Vol.155 (2), p.120-136

2020

Volltextzugriff (PDF)

Poor physical performance and dementia in the oldest old: the 90+ study

JAMA neurology, 2013-01, Vol.70 (1), p.107

2013

Volltextzugriff (PDF)

Validation of 3‐ and 5‐point severity scales to assess ARIA‐E

Alzheimer's & dementia : diagnosis, assessment & disease monitoring, 2023-10, Vol.15 (4), p.e12503-n/a

2023

Volltextzugriff (PDF)

Communicating mild cognitive impairment diagnoses with and without amyloid imaging

Alzheimer's research & therapy, 2017-05, Vol.9 (1), p.35-35, Article 35

2017

Volltextzugriff (PDF)

In silico exploration of amyloid‐related imaging abnormalities in the gantenerumab open‐label extension trials using a semi‐mechanistic model

Alzheimer's & dementia : translational research & clinical interventions, 2022, Vol.8 (1), p.e12306-n/a

2022

Volltextzugriff (PDF)

Genetically engineered T cells to target EGFRvIII expressing glioblastoma

Journal of neuro-oncology, 2009-09, Vol.94 (3), p.373-382

2009

Volltextzugriff (PDF)

HISTORY OF VASCULAR DISEASE AND RISK OF DEMENTIA IN THE OLDEST-OLD: THE 90+ STUDY

Alzheimer's & dementia, 2016-07, Vol.12 (7), p.P249-P250

2016

Volltextzugriff (PDF)

Amyloid imaging and cognitive decline in nondemented oldest-old: The 90+ Study

Alzheimer's & dementia, 2013-03, Vol.9 (2), p.199-203

2013

Volltextzugriff (PDF)

Successful inhibition of intracranial human glioblastoma multiforme xenograft growth via systemic adenoviral delivery of soluble endostatin and soluble vascular endothelial growth factor receptor-2

Journal of neurosurgery, 2008-05, Vol.108 (5), p.979-988

2008

Volltextzugriff (PDF)

THE ASSOCIATION BETWEEN MEASURED BLOOD PRESSURE AND INCIDENT DEMENTIA IN THE OLDEST OLD: THE 90+ STUDY

Alzheimer's & dementia, 2014-07, Vol.10 (4), p.P501-P502

2014

Volltextzugriff (PDF)

AGE OF ONSET OF HYPERTENSION AND RISK OF DEMENTIA IN THE OLDEST-OLD: THE 90+ STUDY

Alzheimer's & dementia, 2014-07, Vol.10 (4), p.P501-P501

2014

Volltextzugriff (PDF)

SMALL-VESSEL CEREBROVASCULAR PATHOLOGY IS ASSOCIATED WITH INCREASING ODDS OF POOR PHYSICAL PERFORMANCE IN THE OLDEST-OLD: THE 90+ STUDY

Alzheimer's & dementia, 2014-07, Vol.10 (4), p.P267-P268

2014

Volltextzugriff (PDF)

Successful inhibition of intracranial human glioblastoma multiforme xenograft growth via systemic adenoviral delivery of soluble endostatin and soluble vascular endothelial growth factor receptor-2: laboratory investigation

Journal of neurosurgery, 2008-05, Vol.108 (5), p.979-988

2008

Volltextzugriff (PDF)

COMMUNICATING MILD COGNITIVE IMPAIRMENT DIAGNOSIS WITH AND WITHOUT AMYLOID IMAGING: RECOMMENDATIONS FROM AN EXPERT WORKGROUP

Alzheimer's & dementia, 2016-07, Vol.12 (7), p.P1160-P1160

2016

Volltextzugriff (PDF)

Baseline risk factors for developing ARIA‐E from the SCarlet RoAD and Marguerite RoAD open‐label extension studies

Alzheimer's & dementia, 2022-12, Vol.18 (S10), p.n/a

2022

Volltextzugriff (PDF)

054 Baseline characteristics of the Phase III GRADUATE studies: investigating subcu- taneous gantenerumab in early AD

Journal of neurology, neurosurgery and psychiatry, 2022-09, Vol.93 (9), p.e2

2022

Volltextzugriff (PDF)

052 SKYLINE study design efficacy and safety of gantenerumab in participants at-risk for Alzheimer’s disease

Journal of neurology, neurosurgery and psychiatry, 2022-09, Vol.93 (9), p.e2

2022

Volltextzugriff (PDF)

Baseline Characteristics of the GRADUATE Studies: Phase III Randomized, Placebo-Controlled Studies Investigating Subcutaneous Gantenerumab in Participants with Early Alzheimer’s Disease (P16-3.005)

Neurology, 2022-05, Vol.98 (18_supplement)

2022

Volltextzugriff (PDF)

Dementia in the oldest old

Continuum (Minneapolis, Minn.), 2013-04, Vol.19 (2 Dementia), p.457-469

2013

Volltextzugriff (PDF)

The Recognition and Management of Psychological Reactions to Stroke: A Case Discussion

Primary care companion for CNS disorders, 2006, Vol.8 (4)

2006

Volltextzugriff (PDF)

1 – 25 von 54

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(54)

Sprache

Englisch
(54)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Multiple pathologies are common and related to dementia in the oldest-old: The 90+ Study

Age of onset of hypertension and risk of dementia in the oldest-old: The 90+ Study

Late-Onset Alzheimer Disease

Sound Body Sound Mind? Physical Performance and the Risk of Dementia in the Oldest-Old: The 90+ Study

Development of third generation anti-EGFRvIII chimeric T cells and EGFRvIII-expressing artificial antigen presenting cells for adoptive cell therapy for glioma

What works and what does not work in Alzheimer’s disease? From interventions on risk factors to anti‐amyloid trials

Poor physical performance and dementia in the oldest old: the 90+ study

Validation of 3‐ and 5‐point severity scales to assess ARIA‐E

Communicating mild cognitive impairment diagnoses with and without amyloid imaging

In silico exploration of amyloid‐related imaging abnormalities in the gantenerumab open‐label extension trials using a semi‐mechanistic model

Genetically engineered T cells to target EGFRvIII expressing glioblastoma

HISTORY OF VASCULAR DISEASE AND RISK OF DEMENTIA IN THE OLDEST-OLD: THE 90+ STUDY

Amyloid imaging and cognitive decline in nondemented oldest-old: The 90+ Study

Successful inhibition of intracranial human glioblastoma multiforme xenograft growth via systemic adenoviral delivery of soluble endostatin and soluble vascular endothelial growth factor receptor-2

THE ASSOCIATION BETWEEN MEASURED BLOOD PRESSURE AND INCIDENT DEMENTIA IN THE OLDEST OLD: THE 90+ STUDY

AGE OF ONSET OF HYPERTENSION AND RISK OF DEMENTIA IN THE OLDEST-OLD: THE 90+ STUDY

SMALL-VESSEL CEREBROVASCULAR PATHOLOGY IS ASSOCIATED WITH INCREASING ODDS OF POOR PHYSICAL PERFORMANCE IN THE OLDEST-OLD: THE 90+ STUDY

Successful inhibition of intracranial human glioblastoma multiforme xenograft growth via systemic adenoviral delivery of soluble endostatin and soluble vascular endothelial growth factor receptor-2: laboratory investigation

COMMUNICATING MILD COGNITIVE IMPAIRMENT DIAGNOSIS WITH AND WITHOUT AMYLOID IMAGING: RECOMMENDATIONS FROM AN EXPERT WORKGROUP

Baseline risk factors for developing ARIA‐E from the SCarlet RoAD and Marguerite RoAD open‐label extension studies

054 Baseline characteristics of the Phase III GRADUATE studies: investigating subcu- taneous gantenerumab in early AD

052 SKYLINE study design efficacy and safety of gantenerumab in participants at-risk for Alzheimer’s disease

Baseline Characteristics of the GRADUATE Studies: Phase III Randomized, Placebo-Controlled Studies Investigating Subcutaneous Gantenerumab in Participants with Early Alzheimer’s Disease (P16-3.005)

Dementia in the oldest old

The Recognition and Management of Psychological Reactions to Stroke: A Case Discussion

Suchergebnisse filtern